Grx1 or Prx2 treatment did not improve visual OVA-induced histological parameters such as eosinophilia or goblet cell hyperplasia (Figure 2, OVA/Grx1, OVA/Prx2) similar to sham-treated OVA-sensitized/challenged animals. The gene discussed is PRDX2; the disease is Increased total eosinophil count.